M. Ross Johnson
Direktor/Vorstandsmitglied bei Nuada Pharmaceuticals, Inc.
Profil
M.
Ross Johnson is currently a Director at Nuada Pharmaceuticals, Inc. and a Director-Education Advancement Board at The University of North Carolina at Charlotte.
He was formerly the Chairman at Mast Therapeutics, Inc. from 2002 to 2007, an Independent Director at RespireRx Pharmaceuticals, Inc. from 2011 to 2013, and the President, Chief Executive & Scientific Officer at Trimeris, Inc. from 1995 to 1999.
He was also a Member-Governors Board at Research Triangle Institute, a Principal at Pfizer Central Research, and the Vice President-Chemistry at Glaxo, Inc. from 1987 to 1994.
Johnson received his undergraduate degree from the University of California, Berkeley and his doctorate from the University of California, Santa Barbara.
Aktive Positionen von M. Ross Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
Nuada Pharmaceuticals, Inc.
 Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Direktor/Vorstandsmitglied | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | 16.06.2011 |
Ehemalige bekannte Positionen von M. Ross Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 22.03.2013 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Vorsitzender | 06.03.2007 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Präsident | 01.01.1999 |
| Glaxo, Inc. | Corporate Officer/Principal | 01.01.1994 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ausbildung von M. Ross Johnson
| University of California, Berkeley | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Health Technology |
Research Triangle Institute
 Research Triangle Institute Miscellaneous Commercial ServicesCommercial Services Research Triangle Institute is a non-profit organization which provides research and development services. It offers surveys and data collection, statistics and data science, assessment and analysis, program design and implementation, and research technologies and analytical laboratory. The company was founded in 1958 and is headquartered in Research Triangle Park, NC. | Commercial Services |
| Glaxo, Inc. |
